Professor of Psychiatry and Behavioral Sciences, Professor of Pediatrics, Johns Hopkins University School of Medicine; Leonard and Helen R. Stulman Professor in Child and Adolescent Psychiatry, Director, Division of Child and Adolescent Psychiatry, Vice C
Psychiatry
Dr. Robert L. Findling, MD
|
|
Give Review
Dr. Robert L. Findling works in the field of Psychiatry. He went to Mount Sinai School of Medicine. Robert Findling is also a published doctor. He has 101 publication published. The most recent publication is: Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo...
Publications
- Pharmacotherapy for mental health problems in people with intellectual disability.
- Ten-year updated meta-analysis of the clinical characteristics of pediatric mania and hypomania.
- Impact of Irritability and Impulsive Aggressive Behavior on Impairment and Social Functioning in Youth with Cyclothymic Disorder.
- Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?
- Predicting clinical outcome from reward circuitry function and white matter structure in behaviorally and emotionally dysregulated youth.
- Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo...
- Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study.
- Parents' Perceived Treatment Match and Treatment Retention Over 12 Months Among Youths in the LAMS Study.
- An update on pharmacotherapy for autism spectrum disorder in children and adolescents.
- White Matter Structure in Youth With Behavioral and Emotional Dysregulation Disorders: A Probabilistic Tractographic Study.
- Decreased amygdala-insula resting state connectivity in behaviorally and emotionally dysregulated youth.
- Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, an...
- Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children.
- Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyper...
- Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial.
- Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD.
- Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder.
- Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder.
- Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS).
- Behavioral and emotional dysregulation trajectories marked by prefrontal-amygdala function in symptomatic youth.
- A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability asso...
- Parsing Dimensional vs Diagnostic Category-Related Patterns of Reward Circuitry Function in Behaviorally and Emotionally Dysregulated Youth in the Longitudinal Assessm...
- Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.
- Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.
- Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.
- Reward dysregulation and mood symptoms in an adolescent outpatient sample.
- Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
- Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
- Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
- Challenges in the transition of care for adolescents With attention-deficit/hyperactivity disorder.
- Age differences in the phenomenology of pediatric bipolar disorder.
- Examining the validity of cyclothymic disorder in a youth sample: replication and extension.
- Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms.
- Post-acute effectiveness of lithium in pediatric bipolar I disorder.
- Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder.
- Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
- Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimes...
- A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
- Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
- An update on antidepressant use and suicidality in pediatric depression.
- What differentiates children visiting outpatient mental health services with bipolar spectrum disorder from children with other psychiatric diagnoses?
- Pediatric bipolar disorder and ADHD: Family history comparison in the LAMS clinical sample.
- Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
- Validation of Proposed DSM-5 Criteria for Autism Spectrum Disorder.
- Experts' recommendations for treating maladaptive aggression in youth.
- Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
- Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders.
- The Treatment of Severe Child Aggression (TOSCA) Study: Design Challenges.
- Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.
- Informants are not all equal: predictors and correlates of clinician judgments about caregiver and youth credibility.
- Informant discrepancies in clinical reports of youths and interviewers' impressions of the reliability of informants.
- Is caregiver-adolescent disagreement due to differences in thresholds for reporting manic symptoms?
- Portability of a screener for pediatric bipolar disorder to a diverse setting.
- The effects of including a callous-unemotional specifier for the diagnosis of conduct disorder.
- An Open-Label Study of Aripiprazole in Children with a Bipolar Disorder.
- Pediatric bipolar spectrum disorder and ADHD: comparison and comorbidity in the LAMS clinical sample.
- Clinical characteristics of children receiving antipsychotic medication.
- Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
- Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity.
- Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD.
- Mental Health Service Use by Children With Serious Emotional and Behavioral Disturbance: Results From the LAMS Study.
- Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.
- Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
- Structure and measurement of depression in youths: Applying item response theory to clinical data.
- ADHD: Current and Future Therapeutics.
- Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
- Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders.
- Examining the validity of cyclothymic disorder in a youth sample.
- Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.
- Changes in emotions related to medication used to treat ADHD. Part I: literature review.
- Psychopharmacology of pediatric bipolar disorders in children and adolescents.
- Assessment of core competencies in childhood attention-deficit/hyperactivity disorder practice.
- Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate.
- Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.
- Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
- Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.
- A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/...
- First-dose pharmacokinetics of lithium carbonate in children and adolescents.
- A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADH...
- Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
- Neurocognition in early-onset schizophrenia and schizoaffective disorders.
- Predictors of Non-Stabilization during the Combination Therapy of Lithium and Divalproex in Rapid Cycling Bipolar Disorder: A Post-hoc Analysis of Two Studies.
- Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developm...
- Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Doub...
- Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
- Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization study.
- Diagnosis and treatment of bipolar disorder in young patients.
- Safety and tolerability of bipolar disorder treatment in youth.
- An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.
- Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
- Treatment options for children and adolescents with bipolar disorder.
- An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
- Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-labe...
- A linguistic analysis of in-office dialogue among psychiatrists, parents, and child and adolescent patients with ADHD.
- Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessment.
- Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
- Quality of life in pediatric bipolar disorder.
- AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions.
- Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
- A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring ...
Schools
Virginia Commonwealth University Medical College Of Virginia School Of Medicine
Mt Sinai Hospital
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Mount Sinai School of Medicine -
Virginia Commonwealth University School of Medicine
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Similar Doctors
|
Dr. Hareendra G. Adhvaryu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jyoti Aneja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erica M. New, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ewald Horwath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jasdeep Sohi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emad N. Estemalik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smita R. Gautam, MD |
|
|
Dr. Richard B. Corradi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Mansour, DO |
|
|
Dr. Edward J. Kilbane, MD |
|
|
Dr. Jacob M. McGrath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Lilian G. Ebrahim |